An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Trial Design and Baseline Characteristics

類似資料

• Application of Adaptive Design Methodology in Development of a Long-Acting Glucagon-Like Peptide-1 Analog (Dulaglutide): Statistical Design and Simulations
  著者:: Skrivanek, Zachary, 等
  出版事項: (2012)
• Operational Challenges and Solutions with Implementation of an Adaptive Seamless Phase 2/3 Study
  著者:: Spencer, Kimberly, 等
  出版事項: (2012)
• A novel, long-acting glucagon-like peptide receptor-agonist: dulaglutide
  著者:: Gurung, Tara, 等
  出版事項: (2015)
• In Vitro and in Vivo Evaluation of Native Glucagon and Glucagon Analog (MAR-D28) during Aging: Lack of Cytotoxicity and Preservation of Hyperglycemic Effect
  著者:: Ward, W Kenneth, 等
  出版事項: (2010)
• Anaphylactic Reaction to Dulaglutide: A Glucagon Like Peptide- 1 Receptor Agonist
  著者:: Quadri, Hamza, 等
  出版事項: (2021)